News

Search here results

• Drug improves survival of patients with rare cancer by almost a quarter | UCL Cancer Institute - UCL – University College London
• Promising pre-clinical results for modified antibody targeting CD25 | UCL Cancer Institute - UCL – University College London
• International team receive $1.2 million boost for neuroendocrine cancer research | UCL Cancer Institute - UCL – University College London
• New region in noncoding DNA linked to leukaemia | UCL Cancer Institute - UCL – University College London
• Combining statins with chemotherapy does not extend survival in lung cancer | UCL Cancer Institute - UCL – University College London
• Scientists reveal variability as key mechanism behind adaptability of immune cells | UCL Cancer Institute - UCL – University College London
• HRH The Duke of Kent visits UCL Cancer Institute | UCL Cancer Institute - UCL – University College London
• New non-invasive test to detect bladder cancer developed | UCL Cancer Institute - UCL – University College London
• Landmark study provides insight into chemotherapy treatment for lung cancer patients | UCL Cancer Institute - UCL – University College London
• New funding for UCL cancer centres announced | UCL Cancer Institute - UCL – University College London